FDA Approves Preventive Migraine Treatment – CNN

Read article - Quotes Stewart Tepper, professor of neurology, about a newly approved drug called Aimovig that's offering hope for reducing the frequency of monthly migraine attacks. Aimovig is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity of calcitonin gene-related peptide (CGRP), a molecule that is involved in migraine attacks. Aimovig targets that molecule's receptor in your body. "When CGRP is released, outside of the brain, it causes inflammation and blood vessel dilation—the blood vessels get big—and that combination of inflammation and blood vessels getting big is the pain of migraine," says Tepper, who was a clinical investigator in the Aimovig trials. (Picked up by WMUR and NBC 5. Similar coverage in The Wall Street Journal, Bustle, Refinery29, The Hindu.)